标题
The IL-8-CXCR1/2 axis contributes to diabetic kidney disease
作者
关键词
-
出版物
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 121, Issue -, Pages 154804
出版商
Elsevier BV
发表日期
2021-06-10
DOI
10.1016/j.metabol.2021.154804
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Innate immunity in diabetic kidney disease
- (2020) Sydney C. W. Tang et al. Nature Reviews Nephrology
- Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria
- (2020) Katsuhito Ihara et al. DIABETES CARE
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- The Antagonist of CXCR1 and CXCR2 Protects db/db mice from Metabolic Diseases through Modulating Inflammation
- (2019) Siyuan Cui et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients
- (2019) Oana Milas et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Role of the Immune System in Diabetic Kidney Disease
- (2018) Fionnuala B. Hickey et al. Current Diabetes Reports
- Biomarkers of diabetic kidney disease
- (2018) Helen M. Colhoun et al. DIABETOLOGIA
- Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
- (2018) Natalia Nowak et al. KIDNEY INTERNATIONAL
- Attracting Attention: Discovery of IL-8/CXCL8 and the Birth of the Chemokine Field
- (2018) Bethany B. Moore et al. JOURNAL OF IMMUNOLOGY
- Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy
- (2018) Yang Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
- (2018) S. Giannattasio et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose–Induced Mesangial Injury
- (2017) Siyuan Cui et al. ENDOCRINOLOGY
- Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing
- (2016) Kanhaiya Singh et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Harnessing the immunological properties of stem cells as a therapeutic option for diabetic nephropathy
- (2014) Francesca D’Addio et al. ACTA DIABETOLOGICA
- The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases
- (2014) Remo C Russo et al. Expert Review of Clinical Immunology
- Role of Podocyte B7-1 in Diabetic Nephropathy
- (2014) P. Fiorina et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes
- (2011) Marcus G. Pezzolesi et al. KIDNEY INTERNATIONAL
- Differential Activation and Regulation of CXCR1 and CXCR2 by CXCL8 Monomer and Dimer
- (2009) M. W. Nasser et al. JOURNAL OF IMMUNOLOGY
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started